Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
15,709,867
Share change
+1,194,026
Total reported value
$431,755,770
Price per share
$27.50
Number of holders
49
Value change
+$32,771,317
Number of buys
25
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q1 2017

As of 31 Mar 2017, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,709,867 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, Redmile Group, LLC, Foresite Capital Management III, LLC, PERCEPTIVE ADVISORS LLC, New Leaf Venture Partners, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.